Phathom Pharmaceuticals
PHAT
PHAT
137 hedge funds and large institutions have $401M invested in Phathom Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
19% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 31
26% less capital invested
Capital invested by funds: $541M → $401M (-$140M)
Holders
137
Holding in Top 10
6
Calls
$915K
Puts
$688K
Top Buyers
| 1 | +$4.39M | |
| 2 | +$3.74M | |
| 3 | +$3.05M | |
| 4 |
Millennium Management
New York
|
+$2.91M |
| 5 |
6CM
683 Capital Management
New York
|
+$2.63M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$5.64M | |
| 3 | -$3.74M | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$3.7M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$3.7M |
